Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study

BMC Gastroenterology
Akpakip I EtteUdeme Ekrikpo

Abstract

Hepatocellular Carcinoma (HCC) is a common malignancy occurring globally but with a dismal prognosis. Des-gamma-carboxyprothrombin (DCP) has been reported to be more sensitive and specific than Alpha-fetoprotein (AFP) in the diagnosis of HCC among the White population. Its efficacy among the Black population is yet to be established. The aim of this study therefore, was to determine the relative sensitivity and specificity of des-gamma-carboxyprothrombin and alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in a cohort of Nigerian patients presenting at a single referral centre. Cross-sectional case-control study was carried out using 62 HCC patients and 57 controls with benign liver diseases including chronic hepatitis and compensated liver cirrhosis. Both DCP and AFP were tested using enzyme immunoassay methods. Sixty-nine percent of the HCC patients presented with tumour sizes >5 cm while 31% presented with tumour sizes 3-5 cm. No patient presented with tumour sizes <3 cm. The sensitivity and specificity of DCP were 96.8% and 98.3% respectively, based on a Receiver operating characteristic (ROC) curve - derived optimum cut-off level of >140mAU/ml. Similarly, the sensitivity and specificity of AFP were 62.9% and ...Continue Reading

References

Mar 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S L TsaiD S Chen
May 31, 1984·The New England Journal of Medicine·H A LiebmanB Furie
Nov 11, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·S UeharaA Hirayama
Dec 29, 2000·Journal of Clinical Gastroenterology·P TangkijvanichY Poovorawan
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mindie H NguyenEmmet B Keeffe
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jorge A MarreroAnna S Lok
Mar 11, 2005·Best Practice & Research. Clinical Gastroenterology·Man-Fung Yuen, Ching-Lung Lai
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Nov 8, 2005·World Journal of Gastroenterology : WJG·Chaur-Shine WangLi-Ying Liao
Jan 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hidenori ToyodaJunji Washizu
Mar 18, 2006·The American Journal of Gastroenterology·Fabio FarinatiFranco Trevisani
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Feb 12, 2008·The American Journal of Medicine·Richard Todd StravitzRobert A Fisher

❮ Previous
Next ❯

Citations

Feb 2, 2019·World Journal of Hepatology·Aakash DesaiDalbir Singh Sandhu
Apr 16, 2021·The Cochrane Database of Systematic Reviews·Agostino ColliGiovanni Casazza

❮ Previous
Next ❯

Software Mentioned

STATA
Excel

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.